JP2023061920A5 - - Google Patents

Info

Publication number
JP2023061920A5
JP2023061920A5 JP2022168144A JP2022168144A JP2023061920A5 JP 2023061920 A5 JP2023061920 A5 JP 2023061920A5 JP 2022168144 A JP2022168144 A JP 2022168144A JP 2022168144 A JP2022168144 A JP 2022168144A JP 2023061920 A5 JP2023061920 A5 JP 2023061920A5
Authority
JP
Japan
Prior art keywords
substituted
group
linear
carbon atoms
hydroxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022168144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023061920A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2023061920A publication Critical patent/JP2023061920A/ja
Publication of JP2023061920A5 publication Critical patent/JP2023061920A5/ja
Pending legal-status Critical Current

Links

JP2022168144A 2021-10-20 2022-10-20 Ｃｄ環側鎖置換ビタミンｄ誘導体 Pending JP2023061920A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021171650 2021-10-20
JP2021171650 2021-10-20

Publications (2)

Publication Number Publication Date
JP2023061920A JP2023061920A (ja) 2023-05-02
JP2023061920A5 true JP2023061920A5 (cg-RX-API-DMAC7.html) 2025-10-09

Family

ID=86058300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022168144A Pending JP2023061920A (ja) 2021-10-20 2022-10-20 Ｃｄ環側鎖置換ビタミンｄ誘導体

Country Status (2)

Country Link
JP (1) JP2023061920A (cg-RX-API-DMAC7.html)
WO (1) WO2023068322A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025108575A1 (en) * 2023-11-21 2025-05-30 Roche Diagnostics Gmbh Methods of selective deprotection and synthesis of transhydrindane- skeleton-based compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003271171A1 (en) * 2002-10-10 2004-05-04 Masato Shimizu 2,2-DI-SUBSTITUTED 1Alpha,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE
WO2004067504A1 (ja) * 2003-01-31 2004-08-12 Chugai Seiyaku Kabushiki Kaisha ２位置換ビタミンｄ誘導体
AU2016268399B2 (en) * 2015-05-26 2020-10-15 Wisconsin Alumni Research Foundation 1alpha,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharmaceutical uses

Similar Documents

Publication Publication Date Title
JP2024105360A5 (cg-RX-API-DMAC7.html)
SE7503519L (sv) Mikrobiocider.
AR037329A1 (es) Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos
UY28878A1 (es) Compuestos de aril-o heteroarilamida ortosustituidos y composiciones
JP2024149717A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2010520243A5 (cg-RX-API-DMAC7.html)
KR970014765A (ko) 신경보호제를 이용한 이명의 치료
JP2014514290A5 (cg-RX-API-DMAC7.html)
JPWO2021030555A5 (cg-RX-API-DMAC7.html)
JP2022023952A5 (cg-RX-API-DMAC7.html)
JPWO2023099623A5 (cg-RX-API-DMAC7.html)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JPWO2021132667A5 (cg-RX-API-DMAC7.html)
KR960022553A (ko) 신규한 에리스로마이신 유도체, 그의 제조 방법 및 의약으로서의 용도
JP2007526331A5 (cg-RX-API-DMAC7.html)
JP2023061920A5 (cg-RX-API-DMAC7.html)
JP2020111571A5 (cg-RX-API-DMAC7.html)
ATE450496T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
JP2005526773A5 (cg-RX-API-DMAC7.html)
JP2008545718A5 (cg-RX-API-DMAC7.html)
JP2010514734A5 (cg-RX-API-DMAC7.html)
JPWO2022251502A5 (cg-RX-API-DMAC7.html)
KR950702554A (ko) 소염제로서 유용한 2-헤테로시클릭-5-히드록시-1,3-피리미딘 (2-Heterocyclic-5-Hydroxy-1,3-Pyrimidines Useful as Antiinflammatory Agents)
JP2006514956A5 (cg-RX-API-DMAC7.html)